Nonfasting remnant cholesterol and cardiovascular disease risk prediction in Albertans: a prospective cohort study
Author:
Publisher
CMA Impact Inc.
Subject
General Medicine
Reference37 articles.
1. 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults
2. Reducing residual risk for patients on statin therapy: the potential role of combination therapy;Davidson;Am J Cardiol,2005
3. Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation
4. Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
5. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin‐Resistant Rats: Acute Treatment Versus Long‐Term Protection as an Idiotypic Vaccine for Atherosclerosis;Journal of the American Heart Association;2024-07-02
2. Predictive utility of remnant cholesterol in atherosclerotic cardiovascular disease;Current Opinion in Cardiology;2024-03-11
3. Elevated remnant cholesterol and non-HDL cholesterol concentrations from real-world laboratory results: a cross-sectional study in Southeast Asians;Frontiers in Cardiovascular Medicine;2024-02-07
4. Cumulative residual cholesterol predicts the risk of cardiovascular disease in the general population aged 45 years and older;Lipids in Health and Disease;2024-01-19
5. Improving a Patient’s CVD Risk Assessment—Updating the Interpretation of the Lipid Profile;World Journal of Cardiovascular Diseases;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3